$Silo Pharma (SILO.US)$Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management 1 MINUTE AGO, 8:05 AM EST VIA GLOBENEWSWIRE Prototype development and feasibility testing underway for optimized subcutaneous delivery
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.